Correction to “Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice”(Neuropsychopharmacol Rep., (2023), 43, (132–136), 10.1002/npr2.12316)

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Amada N, Hirose T, Suzuki M, Kakumoto Y, Futamura T, Maeda K, et al. Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice. Neuropsychopharmacol Rep. 2023;43:132–136. In the ‘Methods’ section of the Abstract, the second sentence is as follows:. “Escitalopram (10 mg/kg), fluoxetine (75 mg/kg), paroxetine (10 mg/kg), or sertraline (15 mg/kg) were orally administered to mice 60 min before testing.”. The amount listed for escitalopram is incorrect. It should be: 60 mg/kg. We apologize for this error.

Cite

CITATION STYLE

APA

Amada, N., Hirose, T., Suzuki, M., Kakumoto, Y., Futamura, T., & Maeda, K. (2024, December 1). Correction to “Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice”(Neuropsychopharmacol Rep., (2023), 43, (132–136), 10.1002/npr2.12316). Neuropsychopharmacology Reports. John Wiley and Sons Inc. https://doi.org/10.1002/npr2.12474

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free